These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37558474)

  • 1. Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.
    Yamauchi H; Momoki M; Kamiyama Y; Gunji T; Yokoyama H; Saito T; Boutboul D; Oksenhendler E; Yano S
    Intern Med; 2024 Apr; 63(7):993-998. PubMed ID: 37558474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colonic Castleman Disease on FDG PET/CT.
    Li F; Xiao L; Cai H; Li L
    Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG-PET/ CT for initial staging and response assessment in Castleman disease - retrospective single-center study of 29 cases.
    Koukalová R; Selingerová I; Řehák Z; Adam Z; Szturz P
    Klin Onkol; 2021; 34(2):120-127. PubMed ID: 33906360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of
    Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
    Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can fluorodeoxyglucose positron emission tomography/computed tomography avoid negative iliac crest biopsies in evaluation of marrow involvement by lymphoma at time of initial staging?
    Mittal BR; Manohar K; Malhotra P; Das R; Kashyap R; Bhattacharya A; Varma N; Varma S
    Leuk Lymphoma; 2011 Nov; 52(11):2111-6. PubMed ID: 21745169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between maximum standardized uptake value measured via
    Li H; Wang X; Zhang L; Yi X; Qiao Y; Jin Q
    J Cancer Res Ther; 2019; 15(7):1581-1588. PubMed ID: 31939441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/CT Findings in TAFRO Syndrome.
    Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
    Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
    El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M
    J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
    Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
    Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    He L; Chen Y; Tan X; Sun X; Zhang Q; Luo H; Jiang L
    Jpn J Radiol; 2023 Jan; 41(1):98-107. PubMed ID: 35895223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients.
    Rossi C; Kanoun S; Berriolo-Riedinger A; Dygai-Cochet I; Humbert O; Legouge C; Chrétien ML; Bastie JN; Brunotte F; Casasnovas RO
    J Nucl Med; 2014 Apr; 55(4):569-73. PubMed ID: 24566003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
    Pelosi E; Pregno P; Penna D; Deandreis D; Chiappella A; Limerutti G; Vitolo U; Mancini M; Bisi G; Gallo E
    Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of mean apparent diffusion coefficient (ADC) and maximal standard uptake value (SUVmax) evaluated by diffusion-weighted MRI and 18F-FDG-PET/CT in children with Hodgkin lymphoma: a feasibility study.
    Rosbach N; Fischer S; Koch V; Vogl TJ; Bochennek K; Lehrnbecher T; Mahmoudi S; Grünewald L; Grünwald F; Bernatz S
    Radiol Oncol; 2023 Jun; 57(2):150-157. PubMed ID: 37341195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma.
    Arslantaş E; Ayçiçek A; Akıcı F; Özkara S; Yılmaz B; Özdemir N; Bayram C
    Nuklearmedizin; 2023 Feb; 62(1):20-26. PubMed ID: 36746148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging.
    Lyapichev KA; You MJ; Vega F; Solis LM; Medeiros LJ
    Virchows Arch; 2020 Sep; 477(3):437-444. PubMed ID: 32152665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of
    Jitani AK; Dutta S; Mandal PK; De R; Jajodia E; Baul S; Chakrabarti P; Dolai TK
    Indian J Med Res; 2021 May; 154(5):691-698. PubMed ID: 35532587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
    Ujjani CS; Hill EM; Wang H; Nassif S; Esposito G; Ozdemirli M; Cordova C; Cheson BD
    Br J Haematol; 2016 Aug; 174(3):410-6. PubMed ID: 27098364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial.
    Picardi M; Cavaliere C; Della Pepa R; Nicolai E; Soricelli A; Giordano C; Pugliese N; Rascato MG; Cappuccio I; Campagna G; Cerchione C; Vigliar E; Troncone G; Mascolo M; Franzese M; Castaldo R; Salvatore M; Pane F
    Ann Hematol; 2021 Jun; 100(6):1525-1535. PubMed ID: 33909101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian Multicenter Study on Accuracy of
    Cistaro A; Cassalia L; Ferrara C; Quartuccio N; Evangelista L; Bianchi M; Fagioli F; Bisi G; Baldari S; Zanella A; Pillon M; Zucchetta P; Burei M; Sala A; Guerra L; Guglielmo P; Burnelli R; Panareo S; Scalorbi F; Rambaldi I; Piccardo A; Garaventa A; Familiari D; Fornito MC; Lopci E; Mascarin M; Altini C; Ferrari C; Perillo T; Santoro N; Borsatti E; Rubini G
    Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e267-e273. PubMed ID: 29739722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.